Ledger.Open graph →
SEC Form D · filed September 21, 2018

VistaGen Therapeutics, Inc

Offering
$5.8M
Sold
$4.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Barrett R. Sigmund · Seattle, WAExecAsia Capital Management, L.P · Grand Cayman, Cayman IslandsExec · DirectorMark W. Brooker · Houston, TXDirectorSteve Wallace · Richmond, VAExecYanghee Paik · Buena Park, CAExecPaul G. Roess · Chattanooga, TNExec · DirectorJoon H. Hwang · Seoul, M5DirectorIshaan Nerurkar · Berkeley, CADirectorMark Rose · Chicago, ILExec · DirectorColton Jang · Berkeley, CAExecDonna Edmonds · Richmond, VADirectorTyler Tringas · Miami, FLDirectorEarl Webb · Chicago, ILExecMichael Theilmann · Berkeley, CAExec · DirectorScott Gazelle · Richmond, VADirectorMark W. Piper · SEATTLE, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗